Sittner & Nelson LLC Decreases Stock Position in The Clorox Company (NYSE:CLX)

Sittner & Nelson LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 15.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 668 shares of the company’s stock after selling 124 shares during the period. Sittner & Nelson LLC’s holdings in Clorox were worth $109,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after buying an additional 48,632 shares during the last quarter. Nuance Investments LLC increased its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Van ECK Associates Corp increased its position in shares of Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after purchasing an additional 120,716 shares in the last quarter. Finally, Acadian Asset Management LLC increased its position in shares of Clorox by 26.5% during the first quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after purchasing an additional 184,847 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their target price for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday. Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. BNP Paribas upgraded Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $155.00.

Clorox Price Performance

Shares of CLX opened at $162.85 on Friday. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $169.09. The stock’s 50 day moving average is $161.89 and its two-hundred day moving average is $146.58. The firm has a market capitalization of $20.16 billion, a PE ratio of 56.74, a P/E/G ratio of 3.02 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the company earned $0.49 EPS. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. Research analysts anticipate that The Clorox Company will post 6.81 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.00%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 170.04%.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.57% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.